All articles by Linda Stewart – Page 88
-
NewsScientists discover new microbial insights hiding above a 60-year-old fire
Soil microbes near the Centralia mine fire reveal new information about how nature responds to — and potentially recovers from — unnatural disasters.
-
News‘Molecular Rosetta Stone’ reveals how our microbiome talks to us
Researchers have uncovered thousands of previously unknown bile acids, a type of molecule used by our gut microbiome to communicate with the rest of the body.
-
NewsCanals used to drain peatlands are underappreciated hotspots for carbon emissions
A study found that one-third of the organic carbon leached from peatland soils into canal waters gets broken down and released into the atmosphere as carbon dioxide.
-
NewsStudy reveals low COVID-19 transmission rate from mothers to newborns
COVID-19 vaccination reduces risks of severe outcomes in pregnant women, who show fewer harmful effects from the Omicron variant, a study shows. It also reveals that COVID-19 transmission from mothers to their newborns is low.
-
NewsHigher bacterial counts detected in single-serving milks
Scientists have detected higher bacterial counts in commercial, paperboard single-serving containers two weeks after processing than milk packaged in larger containers from the same facilities.
-
NewsCOVID-19 had greater impact on life expectancy than previously known, but child mortality rates continued to decline
A new study reveals the staggeringly high mortality from the COVID-19 pandemic within and across countries. Places such as Mexico City, Peru, and Bolivia had some of the largest drops in life expectancy from 2019 to 2021.
-
NewsTuberculosis bacteria present in 90% of those with symptoms - including those who test negative
Mycobacterium tuberculosis (Mtb) is present in exhaled breath of 90% of those presenting with suspected tuberculosis. This includes those who were negative on conventional sputum testing and not diagnosed with TB.
-
NewsVaccine monitoring crucial as SARS-CoV-2 variants continue to evolve
Researchers compared the newer monovalent COVID vaccine, which specifically targets the XBB variant of Omicron, with older bivalent vaccines containing a mix of an Omicron variant and the original strain of COVID-19.
-
NewsBeer byproduct behind Marmite could help us recycle metal waste
When we recycle electronic devices we can no longer use, we expect to make the most out of the precious natural resources that went into building them. But electronic waste is notoriously difficult to recycle, because it’s hard to separate the different metals in the waste from each other. ...
-
NewsMathematicians use AI to identify emerging COVID-19 variants
Scientists have developed an AI framework that can identify and track new and concerning COVID-19 variants and could help with other infections in the future.
-
NewsCommon food ingredient can take a wrong turn, thanks to bacteria, leading to arthritis
Researchers have identified the means in which bacteria in the digestive system can break down tryptophan in the diet into an inflammatory chemical that primes the immune system towards arthritis.
-
NewsCOVID vaccines are safe for pregnant women and babies
The COVID vaccine is safe to administer during pregnancy, reports a new study in an important finding on the safety of the vaccine in infants – despite widespread fear and misinformation.
-
NewsNew dual therapeutic strategy shows promise against multidrug-resistant salmonella
A new collaborative study discloses the discovery and application of a new therapeutic strategy to target the multidrug-resistant bacterium Salmonella enterica in vivo, with promising results. The results were published in Scientific Reports. Source: CDC/ Antibiotic Resistance Coordination and Strategy Unit Medical illustration of drug-resistant, nontyphoidal Salmonella sp. ...
-
NewsCOVID-19 virus can stay in the body more than a year after infection
The COVID-19 virus can persist in the blood and tissue of patients for more than a year after the acute phase of the illness has ended, according to new research that offers potential clues to why some people develop long COVID.
-
NewsStudy probes what makes a pathogen antibiotic-resistant
Researchers describe how two notable pathogens—Escherichia coli and Acinetobacter baumannii—employ distinctly different tools to fend off antibiotic attack.
-
NewsFibrinolytic biomarkers for identifying patients at risk of severe COVID-19
Researchers identify associations between proteins involved in fibrinolysis and the development of acute respiratory distress syndrome.
-
News$12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza
The Access to Advanced Health Institute (AAHI) has been awarded the first stage of funding for a $12.7-million project to develop a novel immune-stimulating adjuvant formulation that will improve the human immune response to vaccines.
-
NewsZika virus vaccine emerges as an unlikely hero in battling brain cancer
Scientists have developed a new approach using the Zika virus to destroy brain cancer cells and inhibit tumour growth, while sparing healthy cells.
-
NewsScientists show how COVID mRNA vaccines reshape immune memory after each dose
Researchers show that T cells can reshape their memory and maintain diversity against different COVID variants in response to successive mRNA vaccinations.
-
NewsWomen with high-risk HPV and metabolic syndrome have almost three times risk for mortality
Women with both metabolic syndrome and high-risk strains of human papillomavirus (HPV) are at a 2.6 times higher risk for mortality than women without either condition.
